The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Marco Cattaneo

Medicina 3

Ospedale San Paolo

Dept. of Internal Medicine

Università degli Studi di Milano

Italy

[email]@unimi.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medicina 3, Ospedale San Paolo, Dept. of Internal Medicine, Università degli Studi di Milano, Italy. 2003 - 2012
  • Unità di Medicina 3, Ospedale San Paolo, Dipartimento di Medicina, Chirurgia e Odontoiatria, Italy. Electronic address:. 2011 - 2012
  • Marco Cattaneo, MD, Medicina 3, Dipartimento di Scienze della Salute, E-mail:. 2012
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, IRCCS Ospedale Maggiore, University of Milano, Italy. 1998 - 2003
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy. 1999

References

  1. Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes. Balduini, A., Di Buduo, C.A., Malara, A., Lecchi, A., Rebuzzini, P., Currao, M., Pallotta, I., Jakubowski, J.A., Cattaneo, M. Haematologica (2012) [Pubmed]
  2. The role of laboratory monitoring in antiplatelet therapy. Cattaneo, M. Handb. Exp. Pharmacol (2012) [Pubmed]
  3. Mechanisms of variability in antiplatelet agents response. Cattaneo, M. Thromb. Res. (2012) [Pubmed]
  4. Why does ticagrelor induce dyspnea? Cattaneo, M., Faioni, E.M. Thromb. Haemost. (2012) [Pubmed]
  5. The clinical relevance of response variability to antiplatelet therapy. Cattaneo, M. Hematology. Am. Soc. Hematol. Educ. Program (2011) [Pubmed]
  6. Molecular defects of the platelet P2 receptors. Cattaneo, M. Purinergic Signal. (2011) [Pubmed]
  7. Resistance to anti-platelet agents. Cattaneo, M. Thromb. Res. (2011) [Pubmed]
  8. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects. Cattaneo, M. Blood (2011) [Pubmed]
  9. Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate. Cattaneo, M. Thromb. Haemost. (2011) [Pubmed]
  10. State of the art of new P2Y12 antagonists. Cattaneo, M., Podda, G.M. Intern. Emerg. Med (2010) [Pubmed]
  11. New P2Y(12) inhibitors. Cattaneo, M. Circulation (2010) [Pubmed]
  12. New P2Y12 blockers. Cattaneo, M. J. Thromb. Haemost. (2009) [Pubmed]
  13. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. Cattaneo, M., Hayward, C.P., Moffat, K.A., Pugliano, M.T., Liu, Y., Michelson, A.D. J. Thromb. Haemost. (2009) [Pubmed]
  14. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Cattaneo, M. Semin. Thromb. Hemost. (2009) [Pubmed]
  15. The use of desmopressin in open-heart surgery. Cattaneo, M. Haemophilia (2008) [Pubmed]
  16. Haemorrhagic stroke during anti-platelet therapy. Cattaneo, M. Eur. J. Anaesthesiol. Suppl (2008) [Pubmed]
  17. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection. Cattaneo, M. J. Thromb. Haemost. (2007) [Pubmed]
  18. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Cattaneo, M., Lecchi, A., Zighetti, M.L., Lussana, F. Haematologica (2007) [Pubmed]
  19. Platelet P2 receptors: old and new targets for antithrombotic drugs. Cattaneo, M. Expert. Rev. Cardiovasc. Ther (2007) [Pubmed]
  20. Laboratory detection of 'aspirin resistance': what test should we use (if any)?. Cattaneo, M. Eur. Heart J. (2007) [Pubmed]
  21. Disorders of platelet function. Abnormalities of the platelet P2 receptors. Cattaneo, M. Pathophysiol. Haemost. Thromb. (2006) [Pubmed]
  22. ADP receptors: inhibitory strategies for antiplatelet therapy. Cattaneo, M. Drug News Perspect. (2006) [Pubmed]
  23. Hyperhomocysteinemia and venous thromboembolism. Cattaneo, M. Semin. Thromb. Hemost. (2006) [Pubmed]
  24. The P2 receptors and congenital platelet function defects. Cattaneo, M. Semin. Thromb. Hemost. (2005) [Pubmed]
  25. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?. Cattaneo, M. J. Thromb. Haemost. (2004) [Pubmed]
  26. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Cattaneo, M. Arterioscler. Thromb. Vasc. Biol. (2004) [Pubmed]
  27. Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Cattaneo, M., Zighetti, M.L., Lombardi, R., Martinez, C., Lecchi, A., Conley, P.B., Ware, J., Ruggeri, Z.M. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  28. Inherited platelet-based bleeding disorders. Cattaneo, M. J. Thromb. Haemost. (2003) [Pubmed]
  29. The platelet P2Y receptors as targets for new antithrombotic drugs. Cattaneo, M. J. Thromb. Haemost. (2003) [Pubmed]
  30. Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis. Cattaneo, M., Lombardi, R., Lecchi, A., Bucciarelli, P., Mannucci, P.M. Circulation (2001) [Pubmed]
  31. Hyperhomocysteinemia and thrombosis. Cattaneo, M. Lipids (2001) [Pubmed]
  32. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Cattaneo, M., Lecchi, A., Lombardi, R., Gachet, C., Zighetti, M.L. Arterioscler. Thromb. Vasc. Biol. (2000) [Pubmed]
  33. Hyperhomocysteinaemia and atherothrombosis. Cattaneo, M. Ann. Med. (2000) [Pubmed]
  34. Hyperhomocysteinemia, atherosclerosis and thrombosis. Cattaneo, M. Thromb. Haemost. (1999) [Pubmed]
  35. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Cattaneo, M., Chantarangkul, V., Taioli, E., Santos, J.H., Tagliabue, L. Thromb. Res. (1999) [Pubmed]
  36. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Cattaneo, M., Federici, A.B., Lecchi, A., Agati, B., Lombardi, R., Stabile, F., Bucciarelli, P. Thromb. Haemost. (1999) [Pubmed]
  37. ADP receptors and clinical bleeding disorders. Cattaneo, M., Gachet, C. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  38. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Cattaneo, M., Lecchi, A., Agati, B., Lombardi, R., Zighetti, M.L. Thromb. Res. (1999) [Pubmed]
  39. Current status of non-transfusional haemostatic agents. Cattaneo, M., Mannucci, P.M. Haematologica (1999) [Pubmed]
  40. Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels. Cattaneo, M., Franchi, F., Zighetti, M.L., Martinelli, I., Asti, D., Mannucci, P.M. Arterioscler. Thromb. Vasc. Biol. (1998) [Pubmed]
  41. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?. Cattaneo, M., Vecchi, M., Zighetti, M.L., Saibeni, S., Martinelli, I., Omodei, P., Mannucci, P.M., de Franchis, R. Thromb. Haemost. (1998) [Pubmed]
 
WikiGenes - Universities